BioRestorative Therapies (BRTX) Net Cash Flow (2010 - 2026)
BioRestorative Therapies (BRTX) reported Net Cash Flow of $1.6 million for Q1 2026, up 135.2% from $680,899 a year earlier and up 73.3% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Net Cash Flow (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioRestorative Therapies' Net Cash Flow came in at $1.87 million; for FY2025, it came in at $952,261.
- Net Cash Flow has a five-year compound annual growth rate of -20.8% (FY2020 to FY2025).
- By year, Net Cash Flow came in at -$336,487 in FY2024, -$829,395 in FY2023, -$19.31 million in FY2022 and $17.96 million in FY2021 (+486.4%).
- The Q1 2026 figure ranks as the highest quarterly Net Cash Flow since Q4 2021.
- Per Business Quant data, the three quarters before Q1 2026 came in at $923,917 (Q4 2025), -$951,670 (Q3 2025) and $299,115 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -4.12 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.21 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.81 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.41 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -799.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.26 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 843.00 Mn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 1.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 923,917.00 |
| Sep 30, 2025 | -951,670.00 |
| Jun 30, 2025 | 299,115.00 |
| Mar 31, 2025 | 680,899.00 |
| Dec 31, 2024 | -941,554.00 |
| Sep 30, 2024 | -762,803.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 272,703.00 |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | 653,223.00 |
| Jun 30, 2023 | -464,524.00 |
| Mar 31, 2023 | 159,892.00 |
| Dec 31, 2022 | -4.86 Mn |
| Sep 30, 2022 | -11.36 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Mar 31, 2022 | -1.70 Mn |
| Dec 31, 2021 | 19.93 Mn |
| Sep 30, 2021 | -629,364.00 |
| Jun 30, 2021 | -741,829.00 |
API Access
BioRestorative Therapies Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();